PATEL JAYENDRAKUMAR DASHARATHLAL has a total of 11 patent applications. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are QINGDAO MERRITT MEDICAL TECHNOLOGY CO LTD, YANTAI HUAWEN XINXIN MEDICINE TECH CO LTD and CUI YINFANG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | United States | 4 | |
#3 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Patel Jayendrakumar Dasharathlal | 11 |
#2 | Patel Shwetaben Dasharathbhai | 5 |
#3 | Patel Shwetaben Dasharathlal | 3 |
#4 | Patel Kaushikakumari Jayendrakumar | 2 |
#5 | Patel Dasharathbhai Trikambhai | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020157730A1 | A controlled release pharmaceutical composition of selexipag or it's active metabolite | |
WO2019064082A2 | Pharmaceutical abuse deterrent composition constructed in more than one strengths | |
US2021046014A1 | Pharmaceutical abuse deterrent composition constructed in more than one strengths | |
US2018064817A1 | Tamper Resistant Pharmaceutical Composition | |
US2017202786A1 | Novel pulsatile drug delivery system | |
WO2016020936A2 | A novel oral gastroretentive pharmaceutical dosage form | |
WO2016046842A1 | Pharmaceutical abuse deterrent composition |